Data demonstrates that secukinumab shows a significantly longer time to flare versus placebo
Month: November 2022
Onivyde regimen demonstrated statistically significant improvement in overall survival
bmj;379/nov08_11/o2697/FAF1faCredit: Avalon.redWhen Steven Daggett, a convicted sex offender, absconded from Ashworth high security psychiatric hospital in September 1996 […]
Frumkin and colleagues discuss the need for hope in tackling the climate emergency.1 Many junior doctors are climate […]
ProductLife becomes partner in upholding regulatory and compliance across life sciences
New access to treatment involves adult patients with hyperkalaemia across Scotland
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who […]
A team of researchers from TU Kaiserslautern (TUK), the University Medical Centre in Mainz and several companies is […]
“We received complaints from women who had to listen to the beating heart of the fetus before being […]
AbstractObjectiveTo develop and externally validate the STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY)-Falls clinical prediction model to […]